Abstract: Abstract The present invention relates to crystalline Roxadustat Form-a and its process for the preparation.
DESC:WE CLAIM:
1) Crystalline Roxadustat Form-a characterized by its powder X-ray diffraction (PXRD) pattern having the peaks at about 5.27, 8.18, 10.55, 11.51, 13.63, 14.51, 17.86, 18.55, 20.26, 20.63 and 24.77 ± 0.20° 2?.
2) Crystalline Roxadustat Form-a substantially as shown in Figure-1.
3) A process for preparation of crystalline Roxadustat Form-a, comprising;
a) Dissolving Roxadustat in solvent comprising acetic acid to obtain the solution and;
b) Isolating crystalline Roxadustat Form-a.
,CLAIMS:WE CLAIM:
1) Crystalline Roxadustat Form-a characterized by its powder X-ray diffraction (PXRD) pattern having the peaks at about 5.27, 8.18, 10.55, 11.51, 13.63, 14.51, 17.86, 18.55, 20.26, 20.63 and 24.77 ± 0.20° 2?.
2) Crystalline Roxadustat Form-a substantially as shown in Figure-1.
3) A process for preparation of crystalline Roxadustat Form-a, comprising;
a) Dissolving Roxadustat in solvent comprising acetic acid to obtain the solution and;
b) Isolating crystalline Roxadustat Form-a.
| # | Name | Date |
|---|---|---|
| 1 | Form2 Title Page_Provisional_19-12-2016.pdf | 2016-12-19 |
| 2 | Description Provisional_As Filed_19-12-2016.pdf | 2016-12-19 |
| 3 | 201641043301-STATEMENT OF UNDERTAKING (FORM 3) [19-12-2016(online)].pdf | 2016-12-19 |
| 4 | 201641043301-PROVISIONAL SPECIFICATION [19-12-2016(online)].pdf | 2016-12-19 |
| 5 | 201641043301-DRAWINGS [19-12-2016(online)].pdf | 2016-12-19 |
| 6 | 201641043301-FORM 3 [18-12-2017(online)].pdf | 2017-12-18 |
| 7 | 201641043301-ENDORSEMENT BY INVENTORS [18-12-2017(online)].pdf | 2017-12-18 |
| 8 | 201641043301-DRAWING [18-12-2017(online)].pdf | 2017-12-18 |
| 9 | 201641043301-COMPLETE SPECIFICATION [18-12-2017(online)].pdf | 2017-12-18 |